UFP Technologies at Midwest IDEAS: growth plan rests on scale

On the 26th of August, 2026, UFP Technologies held the 17th Annual Midwest IDEAS Conference to present a plan for steady growth in the medical device industry. The company, which provides contract development and manufacturing services, currently holds less than 1% of the estimated $100 billion market that is projected to grow by 10% each year.

UFP aims for blended annual growth of 12% to 18% through organic expansion and targeted acquisitions. President and CEO Mitch Roch emphasized UFP's role as a critical supplier in the medical device ecosystem, stating that the company helps customers design, engineer, and manufacture devices, not sell them. Revenue is about $600 million, and the market capitalization is approximately $2.5 billion.

UFP operates in six global locations and employs over 5,000 people. The company's growth strategy is divided into three stages: early development, scale and optimization, and full production. Management highlighted that customer orders for finished goods are driving inventory growth, indicating future demand rather than speculative stocking.

Despite inventory growth being a positive indicator, cash flow is being affected by inventory and receivables, which management attributed to strong business performance and customer demand.